Patents by Inventor Xiangdong Hu

Xiangdong Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250065843
    Abstract: A control system for use at a mobile device to control a digital key system of a vehicle, wherein the digital key system is implemented according to a predetermined vehicle digital key specification to enable one or more vehicle functions to be performed at the vehicle without using a physical key for the vehicle, and wherein the control system, when executed by a processor of the mobile device, is arranged to: communicate, in accordance with the predetermined vehicle digital key specification, with the digital key system via at least one short range communication protocol to cause performance of at least one of the one or more vehicle functions; and provide a secured software runtime environment at the mobile device for the control system to perform one or more secured operations, the one or more secured operations including the control system acting as a software root of trust, in accordance with the predetermined vehicle digital key specification, for performance of at least one of the one or more vehicle
    Type: Application
    Filed: August 21, 2024
    Publication date: February 27, 2025
    Inventors: Xianglong BU, Yaozhang CAI, Yansong GAO, Haiyan HU, Bo WANG, Liyong WU, Xiangdong ZHOU
  • Patent number: 10479805
    Abstract: A beta-lactamase inhibitor having a formula (I). Also provided is a method of using the beta-lactamase inhibitor for prevention or treatment of diseases.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: November 19, 2019
    Assignee: WUHAN VISION PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Shiping Wu, Hongyu Xu, Xiangdong Hu
  • Publication number: 20190048027
    Abstract: A beta-lactamase inhibitor having a formula (I). Also provided is a method of using the beta-lactamase inhibitor for prevention or treatment of diseases.
    Type: Application
    Filed: October 19, 2018
    Publication date: February 14, 2019
    Inventors: Shiping WU, Hongyu XU, Xiangdong HU
  • Patent number: 8524947
    Abstract: The present disclosure relates to acylsulfonamides and processes for their preparation. The processes involve a target-guided synthesis approach, whereby a thioacid and a sulfonyl azide are reacted in the presence of a biological target protein, a Bcl-2 family protein, to form the acylsulfonamide.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: September 3, 2013
    Assignees: University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Hong-Gang Wang, Roman Manetsch, Xiangdong Hu, Sameer Kulkarni, Jiazhi Sun